Purpose: Breast cancer diagnosis and treatment are associated with increased inflammatory activity, which can induce sickness symptoms. We examined whether emotional acceptance moderates the association between proinflammatory cytokines and self-reported sickness symptoms in women recently diagnosed with breast cancer. Methods: Women (N = 136) diagnosed with stage 0-III breast cancer within the previous 6 months provided plasma samples and completed the FACT: Physical Well-Being Scale, as well as the Acceptance of Emotion Scale every 3 months for 2 years. At each time point, we quantified interleukin (IL)-6, IL-8, IL-10, and tumor necrosis factor (TNF)-a using a high sensitivity multiplex assay. Results: Higher within-subject mean TNF-a across all time-points predicted higher mean sickness symptoms. At individual time-points, higher IL-6 and IL-8 levels were associated with higher sickness symptoms. Mean emotional acceptance across all time-points moderated the relationship between mean IL-8 and sickness symptoms, with sickness symptoms remaining persistently high in women with low emotional acceptance even when IL-8 levels were low. At individual time-points, emotional acceptance positively moderated the correlations of IL-8 and TNF-a with sickness symptoms, such that the associations between higher levels of these proinflammatory cytokines and higher sickness symptoms were attenuated when emotional acceptance was high. Conclusion: Emotional acceptance was shown for the first time to moderate the associations of cytokines with sickness symptoms in breast cancer patients over time following diagnosis and treatment. The association between emotional acceptance and sickness symptoms was significantly different from zero but relatively small in comparison to the range of sickness symptoms. Results suggest that targeting emotion regulation may help to break the cycle between inflammation and sickness symptoms in women with breast cancer.
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Introduction
Breast cancer, its treatment, and the associated emotional experiences can influence immune system activity (Seruga et al., 2008) .
Malignant tumor cells and immune cells at the site of the tumor can secrete proinflammatory and immune activating cytokines, creating the systemic paraneoplastic immune response now documented as a consistent pattern in cancer, including increases in macrophage infiltrating factor, tumor necrosis factor (TNF)-a, interleukin (IL)-6, IL-8, IL-10, IL-18, and transforming growth factor (TGF)-b (Lippitz, 2013) . Additionally, cancer treatments such as radiation therapy and chemotherapy can stimulate the immune system to produce proinflammatory cytokines (Grivennikov et al., 2010) . Furthermore, the threats to a woman's goals from breast http://dx.doi.org/10.1016/j.bbi.2016.02.018 0889-1591/Ó 2016 Elsevier Inc. All rights reserved.
Abbreviations: IFN, interferon; IL, interleukin; TNF, tumor necrosis factor; EA, emotional acceptance.
